Transcatheter Structural Heart Device Market Growth Drivers, Trends, and Forecast by 2031

MARKET INTRODUCTION

Transcatheter aortic valve replacement (TAVR) is a new option for the treatment of aortic valve disease with minimally invasive surgery. The TAVR surgery has enhanced the possibilities for replacing the aortic valve. The transcatheter treatment has benefits over surgical intervention in recovery time, lower procedural risk, improved patient satisfaction, and avoidance of cardio-pulmonary bypass, especially in high-risk patients. The transcatheter implant is used in close the left atrial appendage (LAA), a pouch that forms part of the left atrium.

MARKET DYNAMICS

Factors driving the growth of the regulatory approvals of new and advanced structural heart devices market are, coupled with the growing prevalence of structural heart diseases. However, the high cost of cardiac surgeries is expected to hamper the growth of the market. Moreover, favorable reimbursement scenario and rising investments by major market players in transcatheter structural heart device is anticipated to boost the market growth.

MARKET SCOPE

The "Transcatheter Structural Heart Device Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of transcatheter structural heart device market with detailed market segmentation by type and application. The transcatheter structural heart device market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in transcatheter structural heart device market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The transcatheter structural heart device market is segmented on the basis of type and application. Based on type, the market is segmented as aortic valve replacement, left atrial appendage occluders, septal defect occluders, mitral valve repair, and mitral valve replacement (experimental). On the basis of application, the market is categorized as congenital heart defects, aortic stenosis, stroke, mitral regurgitation, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the transcatheter structural heart device market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The transcatheter structural heart device market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting transcatheter structural heart device market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the transcatheter structural heart device market in these regions.

MARKET PLAYERS

The report covers key developments in the transcatheter structural heart device market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from transcatheter structural heart device market are anticipated to have lucrative growth opportunities in the future with the rising demand for transcatheter structural heart device in the global market. Below mentioned is the list of few companies engaged in the transcatheter structural heart device market.

The report also includes the profiles of key players in transcatheter structural heart device market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  Medtronic
  
•  Boston Scientific Corporation
  
•  Abbott Laboratories
  
•  LivaNova plc
  
•  Edwards Lifesciences Corporation
  
•  Lepu Medical
  
•  Micro Interventional Devices, Inc.
  
•  Lifetech Scientific
  
•  Cryolife
  
•  Micro Interventional Devices, Inc.
  
•  NeovasCryoLife, Inc.
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Transcatheter Structural Heart Device Report Scope